Thanks for your message. I have found over decades that one...

Thanks for your message.
I have found over decades that one can't trust any thing in the market even when IM and Lazard etc have invested.
Look at what happened to SGH re analysts views and management guidance.
Many analysts get it wrong many times.
Our best bet is our own research,then looking at the charts on our own and managing our risk.
I understand pharma /health industry to its core.
The facilities they are setting up are great and in USA.
Free cash flow of 100 million plus is what keeping them afloat.
Otherwise shorts would kill it.
If what the management has said in Feb turns out to be true and there is further improvement when annual numbers come in August 2018 we will have a run towards and may be above 100.
If market does not like it, then even those who have gone longs in anticipation will dump it even with a risk of 59 being broken.
Just depends how good or bad the numbers are and what market thinks about them.
GLTA .
DYOR